- Home
- ABEO vs MVBF Comparison
ABEO vs MVBF Comparison
Compare ABEO & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- MVBF
- Stock Information
- Founded
- ABEO 1974
- MVBF 1997
- Country
- ABEO United States
- MVBF United States
- Employees
- ABEO N/A
- MVBF N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- ABEO Health Care
- MVBF Finance
- Exchange
- ABEO Nasdaq
- MVBF Nasdaq
- Market Cap
- ABEO 256.9M
- MVBF 278.3M
- IPO Year
- ABEO 1980
- MVBF N/A
- Fundamental
- Price
- ABEO $5.85
- MVBF $23.85
- Analyst Decision
- ABEO Strong Buy
- MVBF Buy
- Analyst Count
- ABEO 6
- MVBF 5
- Target Price
- ABEO $18.00
- MVBF $25.40
- AVG Volume (30 Days)
- ABEO 1.1M
- MVBF 48.4K
- Earning Date
- ABEO 08-11-2025
- MVBF 07-28-2025
- Dividend Yield
- ABEO N/A
- MVBF 2.87%
- EPS Growth
- ABEO N/A
- MVBF N/A
- EPS
- ABEO N/A
- MVBF 1.46
- Revenue
- ABEO N/A
- MVBF $146,101,000.00
- Revenue This Year
- ABEO N/A
- MVBF N/A
- Revenue Next Year
- ABEO $322.37
- MVBF $14.22
- P/E Ratio
- ABEO N/A
- MVBF $16.25
- Revenue Growth
- ABEO N/A
- MVBF N/A
- 52 Week Low
- ABEO $3.93
- MVBF $15.59
- 52 Week High
- ABEO $7.32
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- ABEO 47.54
- MVBF 79.48
- Support Level
- ABEO $5.68
- MVBF $22.85
- Resistance Level
- ABEO $5.93
- MVBF $23.63
- Average True Range (ATR)
- ABEO 0.26
- MVBF 0.50
- MACD
- ABEO -0.01
- MVBF 0.13
- Stochastic Oscillator
- ABEO 56.25
- MVBF 95.93
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.